TTrialPathMatch Me to Trials
← Back to trials
RecruitingProstate Cancer

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Eligible age

18–100 yrs

Accepts

Men

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Sponsor: University of Oklahoma

You may qualify if…

  • Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
  • At least 18 years-of-age at the time of signature of the informed consent form (ICF).
  • Patients who self-identify as Native American.
  • Patients with a pathologically proven diagnosis of PC (any stage).
  • Availability of most recent archived tumor samples.

You may not qualify if…

  • Patients not of Native American descent or identity.
  • Patient does not have archival tissue available.

Where it's recruiting

Oklahoma

Oklahoma City

Source: ClinicalTrials.gov · NCT06960798 · last updated 2026-08-26

Characterizing the Genomic Landscape of Prostate Cancer in Native Amer · TrialPath